FDA | What's New
Follow
Drug Trials Snapshots: ICOTYDE
ICOTYDE is an interleukin-23 (IL-23) receptor antagonist used for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years of age and older who weigh at least 40 kg and who are candidates for systemic therapy or phototherapy.